Activation of Nrf2 signaling by oltipraz inhibits death of human macrophages with mycobacterium tuberculosis infection-Reference-Cited by-同舟云学术

Activation of Nrf2 signaling by oltipraz inhibits death of human macrophages with mycobacterium tuberculosis infection

Published:2020-10 Issue:3 Volume:531 Page:312-319
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Sun Qin,Shen Xiaona,Ma Jun,Lou Hai,Zhang Qing

Funder

STCSM

China Tuberculosis Clinical Trial Consortium

Shanghai clinical medical research center for Tuberculosis

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference30 articles.

1. Transcriptional landscape of Mycobacterium tuberculosis infection in macrophages;Roy;Sci. Rep.,2018

2. Mycobacterium tuberculosis: Manipulator of protective immunity;Korb;Int. J. Mol. Sci.,2016

3. Cellular and humoral mechanisms involved in the control of tuberculosis;Zuniga;Clin. Dev. Immunol.,2012

4. microRNA-579 upregulation mediates death of human macrophages with mycobacterium tuberculosis infection;Ma;Biochem. Biophys. Res. Commun.,2019

5. Targeting cyclophilin-D by miR-1281 protects human macrophages from Mycobacterium tuberculosis-induced programmed necrosis and apoptosis;Sun;Aging Albany NY,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the role of hypoxia-inducible factors and nuclear factor erythroid 2-related factor 2 in regulating macrophage inflammation and metabolism;Frontiers in Cellular and Infection Microbiology;2024-07-25

2. Activation of Nrf2 antioxidant signaling alleviates gout arthritis pain and inflammation;Biomedicine & Pharmacotherapy;2024-01

3. Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoids;PLOS Pathogens;2023-08-24

4. Identifying autophagy-related genes as potential targets for immunotherapy in tuberculosis;International Immunopharmacology;2023-05

5. Cartilage targeting therapy with reactive oxygen species-responsive nanocarrier for osteoarthritis;Journal of Nanobiotechnology;2022-09-19